What Ortho Clinical Diagnostics Holdings plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Perez David Brian | Director | May 27 | Disposition to Issuer · D | −8,576 | — | — | 0 |
| Carlyle Group Inc. | 10% owner | May 27 | Disposition to Issuer · D | −118,106,000 | — | — | 0 |
| Dilsaver Evelyn S | Director | May 27 | Disposition to Issuer · D | −5,200 | — | — | 0 |
| Smith Christopher M | Chairman and CEO | May 27 | Disposition to Issuer · D | −367,360 | — | — | 0 |
| Yates Robert Clifton | Director | May 27 | Disposition to Issuer · D | −323,880 | — | — | 0 |
| Schlesinger Michael A. | EVP, GC and Secretary | May 27 | Disposition to Issuer · D | −87,637 | — | — | 0 |
| Iskra Michael S. | Executive Vice President | May 27 | Disposition to Issuer · D | −150,000 | — | — | 0 |
| Labrum Ronald K | Director | May 27 | Disposition to Issuer · D | −109,985 | — | — | 0 |
| Bechtel Karen | Director | May 27 | Disposition to Issuer · D | −5,200 | — | — | 0 |
| Mac Mahon Thomas P | Director | May 27 | Disposition to Issuer · D | −79,669 | — | — | 0 |
| Mac Mahon Thomas P | Director | May 27 | Disposition to Issuer · D | −62,184 | — | — | 0 |
| Hull Carl | Director | May 27 | Disposition to Issuer · D | −41,172 | — | — | 0 |
| Hull Carl | Director | May 27 | Disposition to Issuer · D | −21,011 | — | — | 0 |
| Schlesinger Michael A. | EVP, GC and Secretary | Apr 04 | Disclosed 10b5-1 sale · S | −88,043 | $18.77 | −$1.65M | 87,637 |
| Schlesinger Michael A. | EVP, GC and Secretary | Apr 04 | Exercise / conversion · M | +88,043 | $6.28 | +$553K | 175,680 |
| Yates Robert Clifton | Director | Mar 31 | Withheld — tax / exercise cost · F | −214 | $18.66 | −$3.99K | 4,218 |
| Smith Christopher M | Chairman and CEO | Jan 03 | Disclosed 10b5-1 sale · S | −100,000 | $21.10 | −$2.11M | 367,360 |
| Smith Christopher M | Chairman and CEO | Jan 03 | Exercise / conversion · M | +100,000 | $12.56 | +$1.26M | 467,360 |
| Schlesinger Michael A. | EVP, GC and Secretary | Jan 03 | Disclosed 10b5-1 sale · S | −130,000 | $21.09 | −$2.74M | 87,637 |
| Schlesinger Michael A. | EVP, GC and Secretary | Jan 03 | Exercise / conversion · M | +130,000 | $6.28 | +$816K | 217,637 |
Loading...